Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon? - Wikidata - wikimedia - TriplyDB

Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?

Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?

http://www.wikidata.org/entity/Q30238620

about

Persistent atrial fibrillation vs paroxysmal atrial fibrillation: differences in management.

P2860

Q39445718-3B7532B1-BD8C-4C5A-B1B9-09AFD46D1B42

P2860

Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?

http://www.wikidata.org/entity/Q30238620

description

2017 nî lūn-bûn

@nan

2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?

@ast

Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?

@en

type

label

Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?

@ast

Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?

@en

prefLabel

Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?

@ast

Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?

@en

P1433

Q30238620-8F14AE65-5F77-49EC-9860-A65CBC4649E3

P1476

Q30238620-F085E615-881B-42DD-A0F4-D3A587D7752E

P2093

Q30238620-00A2C269-C438-42DD-A726-77A22A39280A

Q30238620-16D6EB8A-2AC1-42EC-A5E6-5FD5A7CD0409

Q30238620-213F8CF4-8DB9-4268-B649-76AAFD335038

Q30238620-35656722-CB0A-458B-9582-3AA3CD524426

Q30238620-629D5599-A361-4CE9-81AC-BED1864CEFAB

Q30238620-845C1C5E-71EB-4D61-985E-33495201D172

P2860

Q30238620-0AC16C4F-B37D-43C1-AD8D-8C8CB90443BB

Q30238620-1A4AF414-CDB6-4848-BCA6-7CD380091BFA

Q30238620-1A968101-05BB-4938-8B5E-6502D006ABC6

Q30238620-1E7DBA84-7F56-4179-8FD3-91EEB408806D

Q30238620-249344AF-1199-4680-89F0-91D966F55614

Q30238620-2902B945-2856-4BBF-A173-117F6C3C64E4

Q30238620-2E18EFD7-7F04-4411-A8FD-AD64B4039A5D

Q30238620-2E3DF9EF-8548-43B3-999D-17D4864709CF

Q30238620-3188234F-EBC1-4B9F-9943-3C88DB77CEF4

Q30238620-31C41FF8-3C39-454A-97F4-006B439E34D7

P304

Q30238620-B6E39D37-9558-491A-8CA4-24DF031ADBF9

P31

Q30238620-C154B2CA-F9EE-4B4D-B284-61D065C224BF

P356

Q30238620-E05592DF-4FF5-4305-94E1-4AFA7A81EA62

P433

Q30238620-D966DA37-9E05-49DA-9B08-CE5DE26310B0

P478

Q30238620-3228AA14-7D95-48E0-B674-10ECABB84630

P50

Q30238620-09EF36AA-ABC6-4CCA-96C3-D5F842ACF5F6

Q30238620-14E27486-E06B-42A1-A998-9834B29B7A33

P577

Q30238620-9DB7275F-2401-454F-9234-CF2C6E2A305F

P698

Q30238620-6977AED0-1CE5-4478-A40C-A8560BD31E16

P356

P1433

Pacing and Clinical Electrophysiology

P1476

Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?

@en

P2093

Bharath Rathakrishnan

http://www.w3.org/2001/XMLSchema#string

Jonathan A Stiber

http://www.w3.org/2001/XMLSchema#string

Kevin L Thomas

http://www.w3.org/2001/XMLSchema#string

Kristen Campbell

http://www.w3.org/2001/XMLSchema#string

Larry R Jackson

http://www.w3.org/2001/XMLSchema#string

Tristram Bahnson

http://www.w3.org/2001/XMLSchema#string

P2860

Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

The Cardiovascular Health Study: design and rationale

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

Pulmonary vein isolation for atrial fibrillation in patients with symptomatic sinus bradycardia or pauses.

Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness.

Incidence of and risk factors for sick sinus syndrome in the general population.

Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study.

Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.

P304

442-450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PACE.13030

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan P Piccini

James P Daubert

P577

2017-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28155995

http://www.w3.org/2001/XMLSchema#string